SYVN1 (Synoviolin 1), also known as HRD1, is an E3 ubiquitin ligase critical for endoplasmic reticulum (ER)-associated degradation (ERAD). FITC-conjugated SYVN1 antibodies are fluorescently labeled probes used to detect and localize SYVN1 protein in cellular studies. These antibodies enable visualization of SYVN1 in immunofluorescence (IF) microscopy, flow cytometry (FCM), and related techniques.
FITC-conjugated SYVN1 antibodies are employed in diverse experimental workflows:
Localization studies: Detect SYVN1 in ER membranes or cytoplasmic aggregates .
Colocalization experiments: Track interactions with ER stress markers (e.g., BiP/GRP78) or autophagy-related proteins (e.g., SQSTM1/p62) .
Quantify SYVN1 expression: Measure protein levels in cell populations, particularly in immune or epithelial cells .
Validate protein degradation: Confirm SYVN1-mediated ubiquitination of substrates (e.g., SIRT2, SERPINA1 E342K/ATZ) .
SYVN1 suppresses ER stress by degrading SIRT2, a regulator of epithelial-mesenchymal transition (EMT). FITC-conjugated antibodies confirmed SYVN1’s colocalization with SIRT2 in bronchial epithelial cells (BEAS-2B), supporting its role in mitigating airway remodeling .
SYVN1 facilitates lysosomal degradation of misfolded proteins (e.g., SERPINA1 E342K/ATZ) via SQSTM1/p62-dependent autophagy. FITC-labeled SYVN1 antibodies enabled visualization of its interaction with lysosomal markers (e.g., LAMP1) in HEK293T cells .
High SYVN1 expression reduced vascular leakage and endothelin-1 (ET-1) levels in diabetic mice. FITC-dextran perfusion assays demonstrated SYVN1’s protective effects against retinal microvascular permeability .